Concepedia
Statistics
Publications
45
Citations
3.6K
H-Index
27
Active since
1984
Affiliations
Biogen (United States)(Current)
University of Pittsburgh
Clovis Oncology (United States)
University of California, Los Angeles
Russell C. Petter is an author at Biogen (United States) specializing in pharmacology, medicinal chemistry, and medicine.
Publications per year
1984–2016
Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC
Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 627 citations · Full text
Medicine, Oncology, Pharmacology +17
Cooperative binding by aggregated mono-6-(alkylamino)-.beta.-cyclodextrins
Russell C. Petter, Jeffrey S. Salek, Christopher T. Sikorski et al. · Journal of the American Chemical Society · 1990 · 468 citations
Pharmacy, Biophysics, Chemistry +14
Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
Erica Evans, Richland Tester, Sharon Aslanian et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 219 citations
Medicine, Immunology, Pharmacology +17
Catalytic hydrolysis of a phosphate triester by tetracoordinated zinc complexes
Samuel H. Gellman, Russell C. Petter, Ronald Breslow · Journal of the American Chemical Society · 1986 · 219 citations
Natural Sciences, Chemistry, Catalysis +11
Targeted covalent drugs of the kinase family
Juswinder Singh, Russell C. Petter, Arthur F. Kluge · Current Opinion in Chemical Biology · 2010 · 177 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–5 of 45